INO80 and cancer: Indeed, we observed a high co-occurrence of alterations in subunits of hINO80 and mTORC1 in a wide range of human cancers (Fig 9 and S9 Table), suggesting that abrogation of both INO80 and mTORC1 may lead to the metabolic dysregulation that contributes to carcinogenesis.